Cartalax 20mg 99% Purity
8 Inquiries
45234-02-4
Pharmaceutical Grade
99%
深圳
20mg/vial, 10vials/box
2026-08-27
Tirzepatide,Retatrutide,Semaglutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Lysylglutamic acid
Other Name:L-Glutamic acid,L-lysyl-;L-Glutamic acid,N-L-lysyl-;Glutamic acid,N-L-lysyl-;L-Lysyl-L-glutamic acid;Lysylglutamic acid;Vilon;Vilon (peptide);1072: PN: EP2071334 SEQID: 1140 claimed protein;1072: PN: WO2009077864 SEQID: 1140 claimed protein;72: PN: EP2161028 PAGE: 10 claimed protein;911649-46-2
CAS No.:45234-02-4
Molecular Formula:C11H21N3O5
InChIKeys:InChIKey=UGTZHPSKYRIGRJ-YUMQZZPRSA-N
Molecular Weight:275.3
Exact Mass:275.30
UNII:H34V7IM5ML
DSSTox ID:DTXSID50196442
HScode:2924199090
Categories:
Characteristics-
PSA:
156
XLogP3:0.66840
Density:1.29 g/cm3
Melting Point:195-197 °C
Boiling Point:596.4ºC at 760 mmHg
Flash Point:314.5ºC
Storage Conditions:-15°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide
-
Location:
Unit 1207, Elevator 1, Office Tower A2, Wanda Plaza, No. 8 Aojiang Road, Taijiang District, Fuzhou City, Fujian Province
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
1
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2024
-
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted 
United Arab Emirates
Vesugen Peptide 98% Powder 45234-02-4 Senwayer
1 G Nov 14, 2023 
United States
Vilon
1 KG Jul 8, 2026 
Brazil
Cartalax
5 MT Apr 17, 2026 
Australia
Cartalax
200 MG Jul 3, 2026
United States
Cartalyx
1 PCS Mar 12, 2026
United States
Cartalax
1 G Jul 25, 2026 
Netherlands
Cartalax
1 G Apr 26, 2026
United States
Vesugen 10mg
20 PCS Mar 3, 2026 Post an enquiry for this product
